EpiWatch, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EpiWatch, Inc. - overview
Established
2020
Location
Baltimore, MD, US
Primary Industry
Healthcare
About
Based in Maryland, US, and founded by Nathan Crone and Gregory Kraus, in 2020, EpiWatch, Inc. , is a digital health company focused on epilepsy. The firm uses technology licensed by Johns Hopkins University. In June 2023, EpiWatch, Inc.
raised USD 1. 5 million in venture funding. As of 2023, the company is led by its CEO, Dean N. Papadopoulos, and Executive Chairman, Michael Singer.
The company is working on a software application as a medical device that connects patients with epilepsy, their caregivers, and their physicians to provide innovative and integrated services to better manage the patient’s condition and provide optimized care for improved outcomes. The digital application of the company helps in reminding for medications, helping understand what triggers the seizures in patients, screening for depression and anxiety, etc. The firm is also developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures in advance.
Current Investors
TEDCO
Primary Industry
Healthcare
Sub Industries
Healthcare, Medical Devices & Equipment
Website
www.epiwatch.com
Verticals
HealthTech, Mobile Apps
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.